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Abstract
Osteoid osteoma is a benign bone-form-
ing tumor with hallmark of tumor cells direct-
ly forming mature bone. Osteoid osteoma
accounts for around 5% of all bone tumors
and 11% of benign bone tumors with a male
predilection. It occurs predominantly in long
bones of the appendicular skeleton.
According to Musculoskeletal Tumor Society
staging system for benign tumors, osteoid
osteoma is a stage-2 lesion. It is classified
based on location as cortical, cancellous, or
subperiosteal. Nocturnal pain is the most
common symptom that usually responds to
salicyclates and non-steroidal anti-inflamma-
tory medications. CT is the modality of
choice not only for diagnosis but also for
specifying location of the lesion, i.e. cortical
vs sub periosteal or medullary. Non-operative
treatment can be considered as an option
since the natural history of osteoid osteoma is
that of spontaneous healing. Surgical treat-
ment is an option for patients with severe pain
and those not responding to NSAIDs.
Available surgical procedures include
radiofrequency (RF) ablation, CT-guided per-
cutaneous excision and en bloc resection.
Introduction
Osteoid osteoma is a benign bone-form-
ing tumor with hallmark of tumor cells
directly forming mature bone.1 These are
small, distinctive, nonprogressive, benign
osteoblastic lesions. Bergstrand first
described osteoid osteoma in 1930 and Jaffe
in 1935 characterized it as a benign
osteoblastic tumor.2,3
Epidemiology
Osteoid osteoma accounts for around
5% of all bone tumors and 11% of benign
bone tumors.4 Osteoid osteoma is the third
most common biopsy analyzed benign bone
tumor after osteochondroma and nonossify-
ing fibroma. Two to 3% of excised primary
bone tumors are osteoid osteomas.5 Males
are more commonly affected with an
approximate male/female ratio of 2 to 1.5
Adolescents and young adults are usually
affected in the second decade of life, with
most patients being under the age of 20
years. It is less likely to be seen in patients
under 5 years of age or in adults greater than
40 years.4
Localisation
Osteoid osteoma occurs predominantly
in the appendicular skeleton. Spine is
involved in one tenth of the cases.6 Flat
bones with intramembraneous formation in
the body and skull are rarely affected. The
lower extremity is more commonly affected
than the upper extremity as shown in Figure
1. Commonly long bones particularly the
femur and tibia are involved, followed far
behind by bones of the feet, with a predilec-
tion for the talar neck. Common sites of
femoral involvement are the juxta- or intra-
articular regions of the femoral neck. In the
upper extremity, phalanges of the hand are
commonly affected.4
Classification
In long bones, osteoid osteoma is more
often situated in the cortico-diaphyseal or
metaphyseal regions, but other localizations
such as intramedullary, subperiosteal, epi-
physeal or apophyseal have also been
noted.6 It is very rare to have two osteoid
osteomas in the same patient.4
According to Musculoskeletal Tumor
Society staging system for benign tumors,
osteoid osteoma is a stage-2 lesion. It is
classified as cortical, cancellous, or subpe-
riosteal. Cortical lesions are most common.4
Clinical presentation
Pain is the most common symptom.
Usually it is a dull ache, which is unremit-
ting and starts off as mild and intermittent
that gradually increases in intensity and per-
sistence. The pain has a tendency to become
increasingly severe at night and usually
responds to salicyclates and non-steroidal
anti-inflammatory medications. If osteoid
osteoma involves a bone in a subcutaneous
location, then the patient usually presents
with swelling, erythema and tenderness. 
If the proximal femur or pelvis is
involved, the patient can present with
referred pain in the knee. Lesions that are
within the joint or juxta-articular can pres-
ent with synovitis. If this continues to
progress, the patient can present with joint
pain, flexion contracture, decreased range
of motion, and a limp or antalgic gait.
Sometimes in children, a limp may be the
only presenting symptom. If the lesion
involves the open physis, it can result in
limb length discrepancy with potential
coronal and/or sagittal malalignment. 
Referred pain and muscle atrophy can
result in misdiagnosis of a neurological dis-
order commonly seen in axial skeleton
involvement with postural scoliosis due to
paravertebral muscle spasm, which is
reversible after treatment.7
Pathogenesis
The exact pathogenesis of osteoid
osteoma remains unknown. High levels of
prostaglandin E2 and prostacyclin have
been found within the nidus that is believed
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to cause local inflammation and vasodilata-
tion. A study by Mungo et al.8 revealed
increased levels of cyclooxygenase-2
expression in nidus osteoblasts.
Cyclooxygenase-2 inhibition is believed to
be a mechanism by which NSAIDs provide
symptomatic relief in osteoid osteomas.
These inflammatory mediators may also
contribute to perilesional sclerosis exhibited
by most osteoid osteomas. In addition, high
concentrations of intralesional unmyelinat-
ed nerve fibers have been implicated in the
pathogenesis of the exquisite nocturnal
pain. These processes probably function in
parallel to produce the characteristic
inflammatory symptoms.9,10
Historically, there has been debate over
the years about the precise nature of osteoid
osteomas. Initially considered a neoplasm
by Jaffe, other investigators proposed a
reactive or reparative process citing its lim-
ited growth potential and its ability to spon-
taneously regress in some cases.2 Currently,
most pathologists agree about the neoplastic
nature of osteoid osteomas. The tumour’s
histological similarity to osteoblastoma
supports the belief that it is a benign tumour
derived from the osteoblasts. There have
been few cytogenetic studies that reported
clonal cytogenetic abnormalities, including
alterations involving chromosome 22q, a
region which contains genes involved in
cell proliferation that is commonly affected
in a variety of other neoplasms.11
Gross features
When removed intact, osteoid osteomas
are usually small, and round to oval in
shape. The cut surface is red to pink when
fresh, and brown to granular after formalin
fixation. They are well demarcated from the
surrounding white sclerotic cortical bone.
The nidus color is related to vascularity of
intertrabecular areas. As osteoid osteomas
are now treated by radiofrequency ablation,
such intact specimens as described above
are rarely received for histopathology.12
Microscopic features
Histologically, the nidus is well circum-
scribed and composed of haphazardly inter-
anastomosing trabeculae of variably miner-
alized woven bone. The trabeculae are usu-
ally thin and short, but can be sclerotic and
broad and are rimmed by a single layer of
osteoblasts. Scattered osteoclasts are also
present on the surface of bony trabeculae
(Figure 2). The osteoblasts are plump, uni-
form in size and shape and have eccentric
nuclei with small nucleoli and open chro-
matin. Cytoplasm is usually amphophilic.
No nuclear pleomorphism or increased
mitotic activity is seen. The intertrabecular
stroma is loose and fibrovascular (Figure 3).
The reactive bone surrounding the nidus is
dense cortical or trabecular bone and when
the tumor grows closer to the bone surface,
it becomes more pronounced. In medullary
lesions, it is less pronounced.13
The pathologic evaluation of osteoid
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Figure 2. Histology of osteoid osteoma. The nidus is composed
of densely broad sclerotic bone trabecuale show osteoblastic rim-
ming and fibrovascular connective tissue.
Figure 1. Pictorial representation of osteoid osteoma.
Figure 3. The bony trabeculae can be thin as seen in this image.
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osteoma has been affected by the increasing
use of radiofrequency ablation (RFA) or
other minimally invasive techniques. The
techniques now used include core biopsy or
biopsy obtained from a drill procedure. As
compared to specimens received by tradi-
tional surgery, the yield of diagnostic tissue
is lower and tissue findings are often
obscured by heat or crushing artifacts.
Consequently, pathologists may or may not
be able to confirm the diagnosis on smaller,
usually fragmented, and frequently distort-
ed fragments of tissue.14
Immunohistochemical features
S100 and neurofilament show nerve fibers
involving tumor.15 Osteoid osteomas also
show strong nuclear expression for Runx2 and
Osterix, which are regulatory transcription fac-
tors. This suggests that osteoid osteomas share
common genetic pathways with normal skele-
tal development.16
Differential diagnosis
Osteoid osteoma can be distinguished
from other bone forming tumors based on
the difference in size, location, pathology,
and clinical symptoms.17 A small Brodie
abscess with a radiolucent center and sur-
rounding reactive sclerosis can mimic
osteoid osteoma. With intracortical Brodie
abscess the sequestrum is irregular in shape
and the inner margin of the lucency is not
smooth, whereas in osteoid osteoma, the
inner margins are usually smooth.18,19
Tumors can also mimic osteoid osteomas.
Chondroblastomas in epiphyseal locations
of children with osteolytic lesions and
extensive bone marrow edema and
periosteal reaction can resemble osteoid
osteoma. However the epiphyseal and
intramedullary location is more characteris-
tic for chondroblastomas, whereas osteoid
osteomas are usually diaphyseal and intra-
cortical. In the pediatric age group cortical
lesions in the tibia caused by osteofibrous
dysplasia, adamantinoma and stress frac-
tures produce cortical thickening and prolif-
eration that can be mistaken for osteoid
osteomas. In stress fractures, the reactive
woven bone network is well oriented
around trabeculae of fractured bone. It is
not haphazard and lacks the small irregular
trabeculae seen in osteoid osteomas. Other
lesions such as nonossifying fibromas,
enchondromas, eosinophilic granulomas,
Perthes disease, tuberculosis, neuromuscu-
lar conditions and malignant bone tumors
can also be considered. In addition to clini-
cal features, imaging techniques such as CT,
bone and SPECT scans can assist in diag-
nosing the lesion. 
Imaging findings
Plain radiography
Osteoid osteoma appears as an oval
lytic lesion located within dense cortical
bone in the diaphysis surrounded by
fusiform cortical bone thickening and scle-
rosis. The cortical based lucency is less than
2 cm.20 Underlying lytic nidus may not
always be visualized due to significant scle-
rosis. The sclerotic reactive bone often is
seen distant from the lesion, in extra capsu-
lar location.
The tumor present at subperiosteal loca-
tion is a rounded sclerotic focus that ele-
vates the periosteum with limited sclerotic
reaction. In intramedullary location, these
tumors are well-circumscribed with a com-
plete or partially calcified nidus. The sur-
rounding reactive sclerosis can be minimal
or absent (Figure 4A). In posterior elements
of the spine, osteoid osteomas are difficult
to localize. The nidus is not visualized on
plain films but additional findings such as
scoliosis with concavity at the side of the
lesion is seen in these cases.6,21 A study done
by PARK et al showed 28.6% of osteoid
osteoma cases in their study had no plain
radiography abnormality despite very typi-
cal clinical presentations. Radionuclide
imaging was used to diagnose these cases.
Therefore in cases where plain radiographs
are not conclusive but clinical suspicion is
high, further imaging workup should be
requested.22
CT
CT is the modality of choice for diagno-
sis and specifying location of lesion, i.e.
cortical vs sub periosteal or medullary. CT
shows well-defined nidus as round or oval
with low attenuation (Figure 5). Nidus can
show mineralization which may be punc-
tate, amorphous or ring like. Surrounding
reactive sclerosis can vary from mild scle-
rosis to extensive periosteal reaction and
new bone formation, which may obscure
the nidus.6
For cases where nonoperative manage-
ment is chosen as the treatment strategy,
mineralization of the nidus is considered as
a marker of age of the lesion. The mineral-
ization ratio of osteoid osteoma increases
significantly with pain duration. Touraine et
al. showed that nidus mineralization ratio of
osteoid osteoma is positively related to pain
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Figure 4. A 10 years old boy with humeral osteoid osteoma. A) AP radiograph shows
radiolucent nidus arrow and surrounding sclerosis. B) Coronal STIR image shows
hypointense lesion long arrow (nidus) and perilesional edema (small arrow). C) Axial
T1-weighted and corresponding post contrast T1-weighted Fat sat images show
hypointense nidus on pre contrast image with intense enhancement on pot contrast
images (long arrow). D) Technetium-99 bone scan, AP projection shows focal region of
radiotracer uptake, corresponding to tumor nidus (Arrow).
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duration and may be a marker of tumor age
(P=0.007, hazard ratio=0.193). They how-
ever reported no association of nidus size
with pain duration (P=0.092). In their study,
diaphyseal osteoid osteomas displayed a
lower ratio of nidus mineralization as com-
pared to those in epiphyseal and metaphy-
seal locations.23
Dynamic contrast-enhanced CT helps in
differentiating osteoid osteoma from bone
cysts and chronic osteomyelitis, specifically
Brodie abscess which are avascular. In these
cases the tumor nidus shows rapid early
arterial enhancement and appears hypervas-
cular.24-26
Spinal osteoid osteoma is better charac-
terized by CT. The nidus is visible as low-
density area in posterior elements.
Surrounding sclerosis of the ipsilateral
pedicle, lamina, or transverse process may
be present.
Bone scintigraphy 
Technetium-99-labeled bone scintigra-
phy has high sensitivity for confirming
diagnosis of osteoid osteoma. The sensitivi-
ty of skeletal scintigraphy for detection is
100%.27 On bone scan characteristic feature
is very intense, round activity at nidus sur-
rounded by less intensity of reactive bone.
This is known as double density sign.28 The
increased intensity of nidus is because of
increased bone turn over. The less intense
peripheral radiotracer uptake, represents the
host bone tumor response (Figure 4) The
sign is infrequently seen with spinal osteoid
osteoma because of less peripheral sclerosis
in vertebral bodies.29 A study done by
PARK et al found out that all the patients in
their study with or without conclusive
appearance on plain radiography, were cor-
rectly identified on bone scintigraphy. They
recommended that if the radionuclide imag-
ing is positive, CT scans should be next
imaging modality for further evaluation but
in cases where radionuclide imaging is neg-
ative, MRI should be done for the diagnosis
of other underlying bone pathologies.22
PET
PET may have role in initial diagnosis
and post treatment follow-up. A study previ-
ously reported that tumor nidus exhibits
18FFDG-avid glucose metabolism, whereas
the surrounding sclerosis does not. In fol-
low up cases of radiofrequency ablation
(RFA), hypermetabolic activity is absent.
Some authors suggested role of PET specif-
ically in cases of spinal osteoid osteoma.
But this modality requires more research
work to be done to prove its utility in diag-
nosis and follow up.30-33
In addition to FDGPET/CT, 68Ga-
PSMA PET/CT, which is used in prostate
cancer staging and restaging, has been used
to detecta case of osteoid osteoma. This
uptake was likely because of osteoblastic
activity in osteoid osteoma but needs fur-
ther evaluation to investigate its specific
role and accuracy in diagnosis of osteoid
osteoma.34,35
MRI
MRI is more sensitive than CT scan for
detection of reactive changes in soft tissue.
MRI is a reliable method of visualizing the
nidus. The MRI appearance of nidus
depends on its location in the cortex. The
closer the lesion is to the medullary zone,
the greater the role of MRI in recognizing
the nidus compared to CT scan. However,
compared to MRI, CT scan is more specific
for identifying a nidus.36,37 The appearance
of nidus on MRI is variable depending on
mineralization and its vascularity. Nidus on
MR T1 weighted sequence appears as round
lesion, slightly hyper intense to intermedi-
ate signals to adjacent muscle and hyper
intense to heterogeneous signals on T2
weighted and STIR sequences (Figure 4B
and C). Nidus can be hypointense in all
sequences, depending on vascularity and
mineralization. Tumor enhancement is vari-
able, can be diffuse or heterogeneous
(Figure 4C). The surrounding osteosclerosis
appears as low signal on both T1- and T2-
weighted sequences.38,39 There is high
potential of misdiagnosing osteoid osteoma
as neoplastic lesion or oversight it when
other modalities are not used for diagnosis.
Small lesions may be hard to isolate on MRI
as nidus signal is frequently similar to that
of surrounding cortex.38 Although CT is the
modality of choice in diagnosis of osteoid
osteoma, but in patients with atypical clini-
cal presentations, in whom the pain does not
respond to NSAIDs and where no obvious
abnormality on plain roentgenograms is
reported, MRI is done to investigate the
underlying cause. MRI is more sensitive
than CT scan for detection of reactive
changes in soft tissue and surrounding bone
edema. Klontzas et al. reported that the
half-moon sign of bone marrow edema was
associated with the presence of osteoid
osteoma in femoral neck. The half-moon
sign is highly specific and sensitive for
presence of osteoid osteoma in the femoral
neck with 94.7% specificity and 100% sen-
sitivity and positive and negative predictive
values of 91.7% and 100%, respectively
(D). But some authors have questioned this
high specificity as the half-moon sign of
bone marrow edema in femoral neck can be
seen in intermediate-grade stress fractures
of the femoral neck on MRI. It has therefore
been recommended that if clinical features
are suggestive of osteoid osteoma, then CT
should be performed to determine the pres-
ence of a potentially occult nidus on MRI.35
Pitfall of imaging
The diagnosis of osteoid osteoma on
imaging can be challenging in cases where
there are severe associated inflammatory
changes such as a prominent periosteal
reaction, exaggerated synovial hypertrophy,
joint effusion, extensive bone marrow and
soft tissue edema. In cases of significant
associated periosteal reaction and soft tissue
edema in a young patient, the differential
diagnoses of osteomyelitis or malignant
bone tumor, such as Ewing sarcoma have to
be considered. A small nidus obscured by
extensive bone marrow and soft-tissue
edema needs to be differentiated from trau-
matic injury or infection. For accurate and
correct radiological diagnosis it is mandato-
ry to identify the nidus. 
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Figure 5. A 14 years old boy osteoid osteoma of right femur. A) axial and B) coronal CT
images show hypoattenuating nidus with surrounding sclerosis.
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Treatment
Non-operative
Non-operative treatment can be consid-
ered as an option since the natural history of
osteoid osteoma is that of spontaneous heal-
ing.40 Moberg40 and Golding41 reported res-
olution of symptoms with conservative
management in osteoid osteoma within 6 to
15 years. Use of aspirin or other nons-
teroidal anti-inflammatory medications
(NSAIDs) decreases this time to 2 to 3
years.42,43 Use of this nonoperative treat-
ment option risks the potential side effects
of protracted NSAID treatment. In anatom-
ical areas where osteoid osteoma is not eas-
ily accessible surgically, this may be a
viable treatment option. However caution
should be exercised with this option, as
there are some reports that these tumors
progress to osteoblastoma with prolonged
NSAID treatment.44
Surgical management
Surgical treatment is an option for
patients with severe pain and those not
responding to NSAIDs. This option should
also be considered for those patients not
willing to tolerate pain and those at particu-
lar risk of long-term renal and gastrointesti-
nal complications of NSAIDs. Moreover in
children with open physes, continued pres-
ence of these tumors can lead to growth dis-
turbances like limb length discrepancies,
scoliosis and osteoarthritis.45 Available pro-
cedures include CT-guided radiofrequency
(RF) ablation, en bloc resection, and CT-
guided percutaneous excision.
En bloc resection
For symptomatic relief, the entire nidus
has to be excised. Complete removal of the
sclerotic reactive bone however, is not
required. Preoperative roentgenograms and
CT scans delineate the location of the nidus.
This resection has the drawback of an open
surgical approach with excision of sclerotic
bone leaving behind a bone defect which
may require bone grafting and internal fixa-
tion with consequent restrictions on postop-
erative activities and weight bearing. With
this approach, intraoperative localization of
the tumor may be challenging leading to
partial removal and potential recurrence.
For structurally critical anatomical sites like
the femoral neck, one can consider deroof-
ing and curettage. For intra-articular loca-
tions of the tumor, arthroscopic excision is a
possible option.46
CT guided percutaneous techniques
Over the years, to reduce the surgical
morbidity of open procedures, several per-
cutaneous techniques using CT guidance
have been used. These include trephine
excision, cryoablation, radiofrequency abla-
tion and laser thermocoagulation.47-51 Fine
drills, bone trephine, Tru-Cut needles, and
cannulated curettes have been used with
percutaneous CT guided techniques per-
formed in the outpatient setting. Using per-
cutaneous CT guided resection, Sans and
colleagues52 showed a cure rate of 84% at
3.7 years with two complications of femoral
fractures at 2 months. For osteoid osteomas
of the hip Muscolo and colleagues53 showed
superior results of percutaneous resection
guided by CT. 
Roqueplan and colleagues54 reported
percutaneous CT guided trephine resection
success rate of 95% at 2 years. Two patients
got skin burns and one had meralgia. The
same authors reported 94% success rate
with interstitial laser ablation at 2 years and
complications of infection, tendonitis,
hematoma, and common peroneal nerve
injury. 
Percutaneous thermocoagulation of
osteoid osteoma was reported by de Berg
and colleagues55 successfully in 17 patients.
Hoffman et al.56 reported 5-year results of
radiofrequency ablation with confirmed
cure in 38 of 39 patients. Complications in
this series included one broken drill and one
case of infection. Papathanassiou et al.57 in
their series of 21 patients over 5 years
reported a primary cure rate of 89.6% that
increased to 93% if a second treatment was
required. Rosenthal and colleagues58 report-
ed their results of CT guided RF ablation in
263 patients. A total of 271 procedures were
performed of which 249 were for initial
tumor treatment, 14 for recurrence after
open excision, and 8 for recurrence after
prior RF ablation. They reported 2 minor
complications and recommended RF abla-
tion as the treatment of choice with 91%
clinical success, brief recovery and low
complication rate.
It is important to note that irrespective
of the technique used, a biopsy is required
to confirm the diagnosis. In order to evalu-
ate complete removal of the nidus, several
techniques have been used which include
roentgenograms, CT scans, and microradi-
ography of specimens. Table l59-118 is a syn-
opsis of the published literature referencing
all case series with more than 15 patients
listing the treatment and outcomes.
Conclusions
Osteoid osteoma is a distinct benign
bone-producing tumor. Nonoperative treat-
ment with NSAIDs is an appropriate option
for pain control. Surgical options should be
considered when conservative treatment
fails or is not indicated for or not opted for
by the patient. Minimally invasive methods
including CT-guided excision and RF abla-
tion have shown promise with highly suc-
cessful outcomes.
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